Jens Panse, Bing Han, Jaroslav Cermak, Fernando Ataulfo Gonzalez Fernandez, Akihiko Gotoh, Austin G Kulasekararaj, Olena Kyselova, Fahri Sahin, Phillip Scheinberg, Hubert Schrezenmeier, Nicole Straetmans, Yasutaka Ueda, Alice C Chang, Brittany Gentile, Jennifer Stefani, Marianne Uguen, Alexander Röth
{"title":"在III期COMMODORE 2和1研究中,克罗伐单抗和批准的C5抑制剂治疗突发性夜间血红蛋白尿患者的患者报告结果","authors":"Jens Panse, Bing Han, Jaroslav Cermak, Fernando Ataulfo Gonzalez Fernandez, Akihiko Gotoh, Austin G Kulasekararaj, Olena Kyselova, Fahri Sahin, Phillip Scheinberg, Hubert Schrezenmeier, Nicole Straetmans, Yasutaka Ueda, Alice C Chang, Brittany Gentile, Jennifer Stefani, Marianne Uguen, Alexander Röth","doi":"10.1007/s00277-025-06449-0","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":8068,"journal":{"name":"Annals of Hematology","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Patient-reported outcomes in patients with paroxysmal nocturnal hemoglobinuria treated with crovalimab and approved C5 inhibitors in the phase III COMMODORE 2 and 1 studies.\",\"authors\":\"Jens Panse, Bing Han, Jaroslav Cermak, Fernando Ataulfo Gonzalez Fernandez, Akihiko Gotoh, Austin G Kulasekararaj, Olena Kyselova, Fahri Sahin, Phillip Scheinberg, Hubert Schrezenmeier, Nicole Straetmans, Yasutaka Ueda, Alice C Chang, Brittany Gentile, Jennifer Stefani, Marianne Uguen, Alexander Röth\",\"doi\":\"10.1007/s00277-025-06449-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":8068,\"journal\":{\"name\":\"Annals of Hematology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-06-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Hematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00277-025-06449-0\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00277-025-06449-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Patient-reported outcomes in patients with paroxysmal nocturnal hemoglobinuria treated with crovalimab and approved C5 inhibitors in the phase III COMMODORE 2 and 1 studies.
期刊介绍:
Annals of Hematology covers the whole spectrum of clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors, and transplantation of hematopoietic stem cells. Coverage includes general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease. The journal is associated with the German Society for Hematology and Medical Oncology, and the Austrian Society for Hematology and Oncology.